Sharing is FON . . . And here’s more to share

When you feel like disclosing - how many routers have you sent to costumers?

It would be great if you guys could open up the source of the FON router allowing us to stick to our committments and still be able to hack on it adding neat features like those found on other OpenWRT routers.

Plus, Martin could get a siesta. :-)

Fon might be about sharing, but Fon isn't sharing much itself. On the boards there are many questions and suggestions, and not many answers, by Fon. It certainly isn't open and transparant, and it's time the Fon management gets out of their ivory tower. I wrote about this on your boards, and emaild martin, but never got a response:
http://boards.fon.com/viewtopic.php?p=9584

By the way: there are no jobs listed on the jobs page..

you folks are funny...
* There was no post to this blog in almost a month, but you claim that "the general public can essentially experience FON’s business decisions in real time"?
* Why is noone (aside from the guest blogger Ross) answering questions or requests in the forums?
Is that so that "the general public can essentially experience FON’s business decisions in real time"?
* Why do you alienate your original user base by not providing essential features (like private and public SSID) to their purchased routers? Where is the upgrade path? Is that decision making process -- where even the only FON person on the boards was puzzled and perplexed -- part of "the general public can essentially experience FON’s business decisions in real time"?
-Th

texas holdem [url=http://hometown.aol.com/youtexasholdem12/]texas holdem[/url] texas hold em [url=http://you-texas-hold-em.blogspot.com/]texas hold em[/url]

On Friday, the first day after Merck's loss of patent exclusivity for the statin Zocor, FDA approved three generic versions of the drug, the Wall Street Journal reports. Teva Pharmaceutical Industries and Ranbaxy Pharmaceuticals for the next 180 days will have exclusive rights to sell generic Zocor, generically known as simvastatin. Teva will sell 5-, 10-, 20- and 40-milligram versions, while Ranbaxy will sell an 80-milligram pill. The generic versions are available at a price that is about 30% less than Zocor's. In addition, Dr. Reddy's Laboratories will sell all five dosages of simvastatin under an agreement with Merck to be the authorized generic manufacturer of the drug. FDA's decision came hours after U.S. District Judge Royce Lamberth denied a motion by Sandoz, Novartis' generic drug unit, to delay the agency's approval of generic versions. Lamberth said the delay could damage the finances of Teva and Ranbaxy and could restrict the public's access to affordable drugs (Won Tesoriero/Zhang, Wall Street Jo
urnal, 6/24). FDA estimated that generic versions of Zocor and other generic drugs approved this week -- versions of baldness drug [url=http://cheap-propecia-store.blogspot.com/]Propecia[/url], prostate drug Proscar and epilepsy treatment Lamictal -- could result in $1 billion per year in savings. Rob Seidman, chief pharmacy officer for WellPoint, said 12 million Medicare Part D beneficiaries who use statins could generate $8.2 billion in savings per year if they switched to generic versions (CQ HealthBeat, 6/23).